Skip to main content
. 2017 Aug 25;7:9555. doi: 10.1038/s41598-017-09352-5

Figure 3.

Figure 3

Urinary flow and glucose excretion in Protocol 2. Intraperitoneal injection of luseogliflozin significantly increased urinary flow (a) and glucose (b) excretion in both SD and Nx SD rats. SD, Sprague Dawley; Nx, 5/6 nephrectomized; vehicle, SD rats treated with vehicle; luseogliflozin, SD rats treated with luseogliflozin; Nx-vehicle, 5/6 Nx SD rats treated with vehicle; Nx-luseogliflozin, 5/6 Nx SD rats treated with luseogliflozin. Values are mean ± SEM. *P < 0.05, ** P < 0.01 and ***P < 0.001 vs. baseline, # P < 0.05, ## P < 0.01 and ### P < 0.001 vs. vehicle, + P < 0.05 and +++ P < 0.001 vs. Nx-vehicle.